These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9754587)

  • 1. Predicting short-term outcome in severely ill heart failure patients: implications regarding listing for urgent cardiac transplantation and patient selection for temporary ventricular assist device support.
    MacGowan GA; Kormos RL; McNamara DM; Alvarez RJ; Rosenblum WD; Pham S; Feldman AM; Murali S
    J Card Fail; 1998 Sep; 4(3):169-75. PubMed ID: 9754587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support.
    Castel MA; Cartañá R; Cardona M; Pereda D; Hernández M; Sandoval E; Castella M; Pérez-Villa F
    Transplant Proc; 2012 Nov; 44(9):2642-4. PubMed ID: 23146481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation: The Registry to Evaluate the HeartWare Left Ventricular Assist System.
    Zimpfer D; Fiane AE; Larbalestier R; Tsui S; Jansz P; Simon A; Schueler S; Strueber M; Schmitto JD
    Circ Heart Fail; 2020 Mar; 13(3):e006252. PubMed ID: 32164438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and management of ventricular assist device patients: the Muenster experience.
    Deng MC; Weyand M; Hammel D; Schmid C; Kerber S; Schmidt C; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S77-82. PubMed ID: 11016493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry.
    Barge-Caballero E; Almenar-Bonet L; Gonzalez-Vilchez F; Lambert-Rodríguez JL; González-Costello J; Segovia-Cubero J; Castel-Lavilla MA; Delgado-Jiménez J; Garrido-Bravo IP; Rangel-Sousa D; Martínez-Sellés M; De la Fuente-Galan L; Rábago-Juan-Aracil G; Sanz-Julve M; Hervás-Sotomayor D; Mirabet-Pérez S; Muñiz J; Crespo-Leiro MG
    Eur J Heart Fail; 2018 Jan; 20(1):178-186. PubMed ID: 28949079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridge to transplantation using paracorporeal biventricular assist devices or the syncardia temporary total artificial heart: is there a difference?
    Nguyen A; Pozzi M; Mastroianni C; Léger P; Loisance D; Pavie A; Leprince P; Kirsch M
    J Cardiovasc Surg (Torino); 2015 Jun; 56(3):493-502. PubMed ID: 24429805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HeartMate left ventricular assist device as bridge to heart transplantation.
    Koul B; Solem JO; Steen S; Casimir-Ahn H; Granfeldt H; Lönn UJ
    Ann Thorac Surg; 1998 Jun; 65(6):1625-30. PubMed ID: 9647070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
    Urban M; Pirk J; Dorazilova Z; Netuka I
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure?
    Bartfay SE; Dellgren G; Lidén H; Holmberg M; Gäbel J; Redfors B; Bech-Hanssen O; Karason K
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):360-367.e1. PubMed ID: 27955912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight.
    Clark AL; Loebe M; Potapov EV; Egerer K; Knosalla C; Hetzer R; Anker SD
    Eur Heart J; 2001 Dec; 22(24):2275-83. PubMed ID: 11728148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It keeps on turning: Effects of prolonged long-term left ventricular assist device support as a bridge to heart transplantation.
    Schmack B; Grossekettler L; Zeriouh M; Weymann A; Mohite P; Koch A; Ruhparwar A; Simon AR; Sabashnikov A; Popov AF
    Int J Artif Organs; 2019 Feb; 42(2):65-71. PubMed ID: 30580668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation.
    Reinhartz O; Farrar DJ; Hershon JH; Avery GJ; Haeusslein EA; Hill JD
    J Thorac Cardiovasc Surg; 1998 Oct; 116(4):633-40. PubMed ID: 9766593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.